Search Results - "McLoughlin, D M"

Refine Results
  1. 1

    Bitemporal v. high-dose right unilateral electroconvulsive therapy for depression: a systematic review and meta-analysis of randomized controlled trials by Kolshus, E, Jelovac, A, McLoughlin, D M

    Published in Psychological medicine (01-02-2017)
    “…Brief-pulse electroconvulsive therapy (ECT) is the most acutely effective treatment for severe depression though concerns persist about cognitive side-effects…”
    Get more information
    Journal Article
  2. 2

    MicroRNAs as biomarkers for major depression: a role for let-7b and let-7c by Gururajan, A, Naughton, M E, Scott, K A, O'Connor, R M, Moloney, G, Clarke, G, Dowling, J, Walsh, A, Ismail, F, Shorten, G, Scott, L, McLoughlin, D M, Cryan, J F, Dinan, T G

    Published in Translational psychiatry (02-08-2016)
    “…There is a growing emphasis in the field of psychiatry on the need to identify candidate biomarkers to aid in diagnosis and clinical management of depression,…”
    Get full text
    Journal Article
  3. 3

    When less is more - microRNAs and psychiatric disorders by Kolshus, E., Dalton, V. S., Ryan, K. M., McLoughlin, D. M.

    Published in Acta psychiatrica Scandinavica (01-04-2014)
    “…Objective MicroRNAs are small non‐coding RNA molecules that regulate gene expression, including genes involved in neuronal function and plasticity that have…”
    Get full text
    Journal Article
  4. 4

    A randomized controlled trial with 4-month follow-up of adjunctive repetitive transcranial magnetic stimulation of the left prefrontal cortex for depression by Mogg, A, Pluck, G, Eranti, S V, Landau, S, Purvis, R, Brown, R G, Curtis, V, Howard, R, Philpot, M, McLoughlin, D M

    Published in Psychological medicine (01-03-2008)
    “…Effectiveness of repetitive transcranial magnetic stimulation (rTMS) for major depression is unclear. The authors performed a randomized controlled trial…”
    Get more information
    Journal Article
  5. 5

    From Molecules to Mind: Mechanisms of Action of Electroconvulsive Therapy by Ryan, K. M, McLoughlin, D. M

    Published in Focus (American Psychiatric Publishing) (01-01-2019)
    “…(Reprinted with permission from Acta Psychatrica Scandinavica (John Wiley & Sons, Ltd.); ©John Wiley & Sons A/S. Published by John Wiley & Sons Ltd. Acta…”
    Get full text
    Journal Article
  6. 6

    Amyotrophic lateral sclerosis mutant vesicle-associated membrane protein-associated protein-B transgenic mice develop TAR-DNA-binding protein-43 pathology by Tudor, E.L, Galtrey, C.M, Perkinton, M.S, Lau, K.-F, De Vos, K.J, Mitchell, J.C, Ackerley, S, Hortobágyi, T, Vámos, E, Leigh, P.N, Klasen, C, McLoughlin, D.M, Shaw, C.E, Miller, C.C.J

    Published in Neuroscience (19-05-2010)
    “…Abstract Cytoplasmic ubiquitin-positive inclusions containing TAR-DNA-binding protein-43 (TDP-43) within motor neurons are the hallmark pathology of sporadic…”
    Get full text
    Journal Article
  7. 7
  8. 8

    Protein aggregates and dementia: is there a common toxicity? by Lovestone, S, McLoughlin, D M

    “…This review considers some of the recent advances made in the understanding of the pathogenic proteins known to aggregate and be implicated in…”
    Get full text
    Journal Article Book Review
  9. 9

    An evoked auditory response fMRI study of the effects of rTMS on putative AVH pathways in healthy volunteers by Tracy, D.K., O’Daly, O., Joyce, D.W., Michalopoulou, P.G., Basit, B.B., Dhillon, G., McLoughlin, D.M., Shergill, S.S.

    Published in Neuropsychologia (01-01-2010)
    “…Auditory verbal hallucinations (AVH) are the most prevalent symptom in schizophrenia. They are associated with increased activation within the temporoparietal…”
    Get full text
    Journal Article
  10. 10
  11. 11
  12. 12

    Peripheral blood microRNA and VEGFA mRNA changes following electroconvulsive therapy: implications for psychotic depression by Kolshus, E., Ryan, K. M., Blackshields, G., Smyth, P., Sheils, O., McLoughlin, D. M.

    Published in Acta psychiatrica Scandinavica (01-12-2017)
    “…Objective MicroRNAs are short, non‐coding molecules that regulate gene expression. Here, we investigate the role of microRNAs in depression and…”
    Get full text
    Journal Article
  13. 13

    A critique of narrative reviews of the evidence-base for ECT in depression by Meechan, C. F., Laws, K. R., Young, A. H., McLoughlin, D. M., Jauhar, S.

    Published in Epidemiology and psychiatric sciences (27-01-2022)
    “…There has been recent debate regarding the efficacy of electroconvulsive therapy in the treatment of depression. This has been based on narrative reviews that…”
    Get full text
    Journal Article
  14. 14

    Serum BDNF as a peripheral biomarker of treatment-resistant depression and the rapid antidepressant response: A comparison of ketamine and ECT by Allen, A.P, Naughton, M, Dowling, J, Walsh, A, Ismail, F, Shorten, G, Scott, L, McLoughlin, D.M, Cryan, J.F, Dinan, T.G, Clarke, G

    Published in Journal of affective disorders (01-11-2015)
    “…Abstract Background Ketamine is associated with rapid antidepressant efficacy but the biological mechanisms underpinning this effect are unclear. Serum…”
    Get full text
    Journal Article
  15. 15

    Kynurenine pathway metabolism and the neurobiology of treatment-resistant depression: Comparison of multiple ketamine infusions and electroconvulsive therapy by Allen, A.P., Naughton, M., Dowling, J., Walsh, A., O'Shea, R., Shorten, G., Scott, L., McLoughlin, D.M., Cryan, J.F., Clarke, G., Dinan, T.G.

    Published in Journal of psychiatric research (01-05-2018)
    “…Current first-line antidepressants can take weeks or months to decrease depressive symptoms. Low dose ketamine, an N-methyl-D-aspartate (NMDA) receptor…”
    Get full text
    Journal Article
  16. 16

    Reduced expression of glucocorticoid-inducible genes GILZ and SGK-1: high IL-6 levels are associated with reduced hippocampal volumes in major depressive disorder by Frodl, T, Carballedo, A, Hughes, M M, Saleh, K, Fagan, A, Skokauskas, N, McLoughlin, D M, Meaney, J, O'Keane, V, Connor, T J

    Published in Translational psychiatry (13-03-2012)
    “…Neuroplasticity may have a core role in the pathophysiology of major depressive disorder (MDD), a concept supported by experimental studies that found that…”
    Get full text
    Journal Article
  17. 17

    Expression of the Fe65 adapter protein in adult and developing mouse brain by Kesavapany, S, Banner, S.J, Lau, K.-F, Shaw, C.E, Miller, C.C.J, Cooper, J.D, McLoughlin, D.M

    Published in Neuroscience (01-01-2002)
    “…Fe65 is a multimodular adaptor protein expressed mainly in the nervous system. Fe65 binds to the Alzheimer’s disease amyloid precursor protein (APP) and the…”
    Get full text
    Journal Article
  18. 18

    Lemur tyrosine kinase-2 signalling regulates kinesin-1 light chain-2 phosphorylation and binding of Smad2 cargo by Manser, C, Guillot, F, Vagnoni, A, Davies, J, Lau, K-F, McLoughlin, D M, De Vos, K J, Miller, C C J

    Published in Oncogene (31-05-2012)
    “…A recent genome-wide association study identified the gene encoding lemur tyrosine kinase-2 ( LMTK2 ) as a susceptibility gene for prostate cancer. The…”
    Get full text
    Journal Article
  19. 19

    Electroconvulsive therapy modulates plasma pigment epithelium-derived factor in depression: a proteomics study by Ryan, K M, Glaviano, A, O'Donovan, S M, Kolshus, E, Dunne, R, Kavanagh, A, Jelovac, A, Noone, M, Tucker, G M, Dunn, M J, McLoughlin, D M

    Published in Translational psychiatry (28-03-2017)
    “…Electroconvulsive therapy (ECT) is the most effective treatment for severe depression, yet its mechanism of action is not fully understood. Peripheral blood…”
    Get full text
    Journal Article
  20. 20

    Structural and functional changes in skeletal muscle in anorexia nervosa by MCLOUGHLIN, D. M, SPARGO, E, WASSIF, W. S, NEWHAM, D. J, PETERS, T. J, LANTOS, P. L, RUSSELL, G. F. M

    Published in Acta neuropathologica (01-06-1998)
    “…Protein-energy malnutrition in anorexia nervosa is an under-recognised cause of muscle dysfunction. To characterise the skeletal myopathy that occurs in…”
    Get full text
    Journal Article